1 |
Celli B, Fabbri L, Criner G, et al. Definition and nomenclature of chronic obstructive pulmonary disease: Time for its revision [J]. Am J Respir Crit Care Med, 2022, 206(11): 1317-1325.
|
2 |
Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study [J]. Lancet, 2018, 391(10131): 1706-1717.
|
3 |
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. Lancet (London, England), 2020, 396(10258): 1204-1222.
|
4 |
Global Initiative for Chronic Obstructive Lung Disease(GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(2022 Report) [EB/OL]. 2021-11-22.
|
5 |
Global Initiative for Chronic Obstructive Lung Disease(GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease(2024 Report) [EB/OL]. 2024-1-11.
|
6 |
Han MK, Agusti A, Celli BR, et al. From GOLD 0 to Pre-COPD [J]. Am J Respir Crit Care Med, 2021, 203(4): 414-423.
|
7 |
Breyer-Kohansal R, Faner R, Breyer MK, et al. Factors associated with low lung function in different age bins in the general population [J]. Am J Respir Crit Care Med, 2020, 202(2): 292-296.
|
8 |
Lei J, Huang K, Wu S, et al. Heterogeneities and impact profiles of early chronic obstructive pulmonary disease status: findings from the China Pulmonary Health Study [J]. Lancet Reg Health West Pac, 2024, 45: 101021.
|
9 |
Wijnant SRA, De Roos E, Kavousi M, et al. Trajectory and mortality of preserved ratio impaired spirometry: the Rotterdam Study [J]. Eur Respir J, 2020, 55(1): 1901217.
|
10 |
Higbee DH, Granell R, Davey Smith G, et al. Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis [J]. Lancet Respir Med, 2022, 10(2): 149-157.
|
11 |
Mannino DM, McBurnie MA, Tan W, et al. Restricted spirometry in the Burden of Lung Disease Study [J]. Int J Tuberc Lung Dis, 2012, 16(10): 1405-1411.
|
12 |
Schwartz A, Arnold N, Skinner B, et al. Preserved ratio impaired spirometry in a spirometry database [J]. Respiratory Care, 2021, 66(1): 58-65.
|
13 |
Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey [J]. Am J Respir Crit Care Med, 2007, 176(8): 753-760.
|
14 |
de Oca MM, Halbert RJ, Lopez MV, et al. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study [J]. Eur Respir J, 2012, 40(1): 28-36.
|
15 |
Mejza F, Gnatiuc L, Buist AS, et al. Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study [J]. Eur Respir J, 2017, 50(5): 1700621.
|
16 |
Wu F, Fan H, Liu J, et al. Association between non-obstructive chronic bronchitis and incident chronic obstructive pulmonary disease and all-cause mortality: A systematic review and meta-analysis [J]. Frontiers in Medicine, 2021, 8: 805192.
|
17 |
Young AL, Bragman FJS, Rangelov B, et al. Disease progression modeling in chronic obstructive pulmonary disease [J]. Am J Respir Crit Care Med, 2020, 201(3): 294-302.
|
18 |
Higham A, Quinn AM, Cançado JED, et al. The pathology of small airways disease in COPD: historical aspects and future directions [J]. Respir Res, 2019, 20(1): 49.
|
19 |
Xiao D, Chen Z, Wu S, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study [J]. Lancet Respir Med, 2020, 8(11): 1081-1093.
|
20 |
Willemse BWM, Postma DS, Timens W, et al. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation [J]. Eur Respir J, 2004, 23(3): 464-476.
|
21 |
Yin P, Jiang CQ, Cheng KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study [J]. Lancet (London, England), 2007, 370(9589): 751-757.
|
22 |
Zhou Y, Zou Y, Li X, et al. Lung function and incidence of chronic obstructive pulmonary disease after improved cooking fuels and kitchen ventilation: a 9-year prospective cohort study [J]. PLoS Med, 2014, 11(3): e1001621.
|
23 |
Grahn K, Gustavsson P, Andersson T, et al. Occupational exposure to particles and increased risk of developing chronic obstructive pulmonary disease (COPD): A population-based cohort study in Stockholm, Sweden [J]. Environ Res, 2021, 200: 111739.
|
24 |
Wang X, Chen L, Cai M, et al. Air pollution associated with incidence and progression trajectory of chronic lung diseases: a population-based cohort study [J]. Thorax, 2023, 78(7): 698-705.
|
25 |
Bui DS, Lodge CJ, Burgess JA, et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life [J]. Lancet Respir Med, 2018, 6(7): 535-544.
|
26 |
Simon S, Joean O, Welte T, et al. The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus [J]. Eur Respir Rev, 2023, 32(169): 230034.
|
27 |
Troosters T, Janssens W, Demeyer H, et al. Pulmonary rehabilitation and physical interventions [J]. Eur Respir Rev, 2023, 32(168): 220222.
|
28 |
Zhou Y, Zhong NS, Li X, et al. Tiotropium in early-stage chronic obstructive pulmonary disease [J]. N Engl J Med, 2017, 377(10): 923-935.
|
29 |
周婷, 孙培培, 张二明, 等. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查 [J/OL]. 中华临床医师杂志(电子版), 2023, 17(7): 790-797.
|